Source: PR
Date: 08:30 AM
PALO ALTO, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Scientists from SLAC ( Stanford Linear Accelerator Center) and Genencor International, Inc. (Nasdaq:
GCOR) announced a breakthrough in the ability to compute, in record time, all
possible metabolic behaviors open to a microorganism.
"This development will allow us to reverse engineer a microorganism to create the product of choice," said Michael V. Arbige, Genencor's senior vice
president, Technology. "We can go from a small target molecule back to the
pathway and then back to the gene. The algorithm will mine the public genomes so
we have a list of gene sequences to assemble the cell factory to express the
target molecule. This important advancement industrializes the process of
developing of co-products in a biorefinery."
The work, which was supported in part by the Department of Energy, will be presented at the upcoming Computational Systems Bioinformatics Conference hosted
by the IEEE Computer Society, August 2004 at Stanford, CA. SLAC and Genencor
scientists constructed a parallel algorithm that accelerates the calculation of
the basis governing all possible metabolic behaviors.
The parallel algorithm can calculate the full spectrum of possible phenotypes in seconds versus hours or even days, as was previously the case. Scientists
from Genencor and SLAC used 70 2.4 GHz Intel Pentium-IV CPUs, to compute, in
under 280 seconds, the more than 10,000 pathways by which Escherichia coli can
consume glycerol.
Since ancient times humans have utilized the metabolic capabilities of microorganisms to generate diverse products including amino acids, antibiotics,
vitamins and alkaloids. A better understanding of how microorganisms work has
increased our ability to exploit them for numerous applications.
One of the best recent examples of modifying the metabolic and physiological properties of microbes to obtain better commercial processes is the development
by Genencor and DuPont (Wilmington, DE) of an E. coli strain that uses corn to
produce 1,3-propanediol (PDO), an intermediate utilized for the production of
polyester fibers such as Sorona(R) for use in clothing, carpets and automobile
interiors. To redirect cellular metabolism towards PDO synthesis, scientists
introduced 20 genomic modifications that affected hundreds of genes within E.
coli. The entire process took several years.
The radical decrease in the time required to compute the reaction spectrum paves the way for new applications in metabolic engineering and beyond. The
applications of such algorithms are numerous-ranging from designing novel ways
for manufacturing biochemicals and biomaterials consistent with the demands for
improved sustainability, to better understanding disease pathways.
About Genencor
Genencor International, Inc. (www.genencor.com) is a diversified biotechnology company that develops and delivers innovative products and
services into the health care, agri-processing, industrial and consumer markets.
Using an integrated set of technology platforms, Genencor's products deliver
innovative and sustainable solutions to improve the quality of life.
Genencor traces its history to 1982 and has grown to become a leading biotechnology company, with over $380 million in year 2003 annual revenues.
Genencor has principal offices in Palo Alto, California; Rochester, New York;
and Leiden, the Netherlands. |
